Covestor’s Meridian Bioscience Inc VIVO Stock Holding History

Covestor’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9	Closed	–	–	2790
2022 Q4	$0	Sell	9 -3	-25%	-$97	﹤0.01%	2807
2022 Q3	$0	Sell	12 -14	-54%	-$453	﹤0.01%	2828
2022 Q2	$1K	Sell	26 -6	-19%	-$162	﹤0.01%	1832
2022 Q1	$1K	Sell	32 -94	-75%	-$2.24K	﹤0.01%	2030
2021 Q4	$3K	Buy	+126	New	+$2.42K	﹤0.01%	1508

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Covestor's VIVO Position: Q1 2023 in Review

Covestor sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 9 shares.

Covestor first reported a position in VIVO in Q4 2021 and held it in 5 quarters. The position peaked at $3K in Q4 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Covestor reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Covestor sold 9 Meridian Bioscience Inc shares in Q1 2023.
Covestor first reported a position in Meridian Bioscience Inc in Q4 2021 and held it in 5 quarters.
Covestor's Meridian Bioscience Inc position peaked at $3K in Q4 2021.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Covestor's 13F filing for Q1 2023, filed 15 May 2023.